These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1780 related articles for article (PubMed ID: 23495938)

  • 41. An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.
    Fanning SW; Horn JR
    Protein Sci; 2011 Jul; 20(7):1196-207. PubMed ID: 21557375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
    Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
    J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel therapy based on camelid nanobodies.
    Unciti-Broceta JD; Del Castillo T; Soriano M; Magez S; Garcia-Salcedo JA
    Ther Deliv; 2013 Oct; 4(10):1321-36. PubMed ID: 24116915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
    Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
    Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Naturally occurring antibodies devoid of light chains.
    Hamers-Casterman C; Atarhouch T; Muyldermans S; Robinson G; Hamers C; Songa EB; Bendahman N; Hamers R
    Nature; 1993 Jun; 363(6428):446-8. PubMed ID: 8502296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunological applications of single-domain llama recombinant antibodies isolated from a naïve library.
    Monegal A; Ami D; Martinelli C; Huang H; Aliprandi M; Capasso P; Francavilla C; Ossolengo G; de Marco A
    Protein Eng Des Sel; 2009 Apr; 22(4):273-80. PubMed ID: 19196718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
    Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
    Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The development of nanobodies for therapeutic applications.
    Van Bockstaele F; Holz JB; Revets H
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies.
    Arbabi Ghahroudi M; Desmyter A; Wyns L; Hamers R; Muyldermans S
    FEBS Lett; 1997 Sep; 414(3):521-6. PubMed ID: 9323027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).
    Maass DR; Sepulveda J; Pernthaner A; Shoemaker CB
    J Immunol Methods; 2007 Jul; 324(1-2):13-25. PubMed ID: 17568607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selection and identification of single-domain antibody fragment against capsid protein of porcine circovirus type 2 (PCV2) from C. bactrianus.
    Yang S; Shang Y; Yin S; Tian H; Chen Y; Sun S; Jin Y; Liu X
    Vet Immunol Immunopathol; 2014 Jul; 160(1-2):12-9. PubMed ID: 24736187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the Potential Impact of In Silico Humanization on V
    Martins C; Diharce J; Nadaradjane AA; de Brevern AG
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Camel heavy chain antibodies against prostate-specific membrane antigen.
    Evazalipour M; Tehrani BS; Abolhassani M; Morovvati H; Omidfar K
    Hybridoma (Larchmt); 2012 Dec; 31(6):424-9. PubMed ID: 23244321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Head-to-tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid.
    Winichayakul S; Pernthaner A; Scott R; Vlaming R; Roberts N
    Biotechnol Appl Biochem; 2009 Jun; 53(Pt 2):111-22. PubMed ID: 18844608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular analysis of heavy chain-only antibodies of Camelus bactrianus.
    Tillib SV; Vyatchanin AS; Muyldermans S
    Biochemistry (Mosc); 2014 Dec; 79(12):1382-90. PubMed ID: 25716733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
    Pain C; Dumont J; Dumoulin M
    Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-domain antibodies for biomedical applications.
    Krah S; Schröter C; Zielonka S; Empting M; Valldorf B; Kolmar H
    Immunopharmacol Immunotoxicol; 2016; 38(1):21-8. PubMed ID: 26551147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ¹⁵N, ¹³C and ¹H resonance assignments and secondary structure determination of a variable heavy domain of a heavy chain antibody.
    Prosser CE; Waters LC; Muskett FW; Veverka V; Addis PW; Griffin LM; Baker TS; Lawson AD; Wernery U; Kinne J; Henry AJ; Taylor RJ; Carr MD
    Biomol NMR Assign; 2014 Apr; 8(1):113-6. PubMed ID: 23359223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A guide to: generation and design of nanobodies.
    Muyldermans S
    FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.